IL128188A0 - ,7-bicyclic derivatives substituted pyrido-or pyrimido-containing 6,6-or 6 - Google Patents

,7-bicyclic derivatives substituted pyrido-or pyrimido-containing 6,6-or 6

Info

Publication number: IL128188A0
Authority: IL; Israel
Prior art keywords: pyrimido; derivatives substituted; substituted pyrido; bicyclic derivatives; bicyclic
Prior art date: 1996-08-06

Application number

IL12818897A

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-06

Filing date

1997-07-23

Publication date

1999-11-30

1997-07-23 Application filed by Pfizer filed Critical Pfizer

1999-11-30 Publication of IL128188A0 publication Critical patent/IL128188A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IL12818897A 1996-08-06 1997-07-23 ,7-bicyclic derivatives substituted pyrido-or pyrimido-containing 6,6-or 6 IL128188A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2345396P	1996-08-06	1996-08-06
PCT/IB1997/000918 WO1998005661A1 (en)	1996-08-06	1997-07-23	Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives

Publications (1)

Publication Number	Publication Date
IL128188A0 true IL128188A0 (en)	1999-11-30

Family

ID=21815208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12818897A IL128188A0 (en)	1996-08-06	1997-07-23	,7-bicyclic derivatives substituted pyrido-or pyrimido-containing 6,6-or 6

Country Status (40)

Country	Link
US (1)	US6492520B1 (es)
EP (1)	EP0920429B1 (es)
JP (1)	JP3345021B2 (es)
KR (1)	KR20000029843A (es)
CN (1)	CN1093130C (es)
AP (1)	AP1096A (es)
AR (1)	AR008829A1 (es)
AT (1)	ATE232863T1 (es)
AU (1)	AU709203B2 (es)
BG (1)	BG103143A (es)
BR (1)	BR9710808A (es)
CA (1)	CA2262692C (es)
CO (1)	CO4900060A1 (es)
CZ (1)	CZ292806B6 (es)
DE (1)	DE69719193T2 (es)
DK (1)	DK0920429T3 (es)
DZ (1)	DZ2289A1 (es)
EA (1)	EA003188B1 (es)
ES (1)	ES2191183T3 (es)
GT (1)	GT199700089A (es)
HR (1)	HRP970432B1 (es)
ID (1)	ID17980A (es)
IL (1)	IL128188A0 (es)
IS (1)	IS4948A (es)
MA (1)	MA24296A1 (es)
NO (1)	NO313293B1 (es)
NZ (1)	NZ333727A (es)
OA (1)	OA10970A (es)
PA (1)	PA8435201A1 (es)
PE (1)	PE97098A1 (es)
PL (1)	PL331602A1 (es)
SA (1)	SA97180334A (es)
SK (1)	SK14099A3 (es)
TN (1)	TNSN97135A1 (es)
TR (1)	TR199900228T2 (es)
TW (1)	TW550265B (es)
UY (1)	UY24655A1 (es)
WO (1)	WO1998005661A1 (es)
YU (1)	YU5399A (es)
ZA (1)	ZA976954B (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
ATE266399T1 (de)	1998-08-20	2004-05-15	Smithkline Beecham Corp	Neue substituierte triazolverbindungen
BR9915129A (pt)	1998-11-12	2001-08-07	Neurocrine Biosciences Inc	Antagonistas do receptor de crf e processos relacionados aos mesmos
US6514982B1 (en)	1998-11-12	2003-02-04	Neurocrine Biosciences, Inc.	CRF receptor antagonists and methods relating thereto
US6432989B1 (en) *	1999-08-27	2002-08-13	Pfizer Inc	Use of CRF antagonists to treat circadian rhythm disorders
IL139197A0 (en) *	1999-10-29	2001-11-25	Pfizer Prod Inc	Use of corticotropin releasing factor antagonists and related compositions
WO2001058489A1 (en) *	2000-02-14	2001-08-16	Japan Tobacco Inc.	Preventives/remedies for postoperative stress
AU2001234180A1 (en) *	2000-02-25	2001-09-03	Japan Tobacco Inc.	Benzamide derivative and use thereof
US7235551B2 (en) *	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
AR030053A1 (es) *	2000-03-02	2003-08-13	Smithkline Beecham Corp	1h-pirimido [4,5-d] pirimidin-2-onas y sales, composiciones farmaceuticas, uso para la fabricacion de un medicamento y procedimiento para producirlas
GB0011964D0 (en)	2000-05-18	2000-07-05	Suyal N	Thick glass films with controlled refractive indices and their applications
CN1847229B (zh)	2000-10-23	2011-05-04	史密丝克莱恩比彻姆公司	2，4，8-三取代-8H-吡啶并[2，3-d]嘧啶-7-酮化合物
GB0117396D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds
BR0212864A (pt)	2001-09-26	2004-08-17	Bayer Pharmaceuticals Corp	Derivados de 1,6-naftiridina como antidiabéticos
EP1499320B1 (en)	2002-04-19	2007-08-22	Smithkline Beecham Corporation	Novel compounds
FR2846657B1 (fr) *	2002-11-05	2004-12-24	Servier Lab	Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7109337B2 (en)	2002-12-20	2006-09-19	Pfizer Inc	Pyrimidine derivatives for the treatment of abnormal cell growth
AU2003285614B2 (en)	2002-12-20	2009-05-14	Pfizer Products, Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
AU2004253967B2 (en)	2003-07-03	2010-02-18	Cytovia, Inc.	4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
US8309562B2 (en)	2003-07-03	2012-11-13	Myrexis, Inc.	Compounds and therapeutical use thereof
WO2005020910A2 (en) *	2003-08-27	2005-03-10	Pharmacia Corporation	Cyclooxygenase-2 selective inhibitor and corticotropin releasing factor antagonist compositions for treating ischemic mediated cns disorders or injuries
CA2562244A1 (en) *	2004-04-07	2005-10-27	Takeda Pharmaceutical Company Limited	Cyclic compounds
JP2007537238A (ja)	2004-05-14	2007-12-20	ファイザー・プロダクツ・インク	異常細胞増殖の治療のためのピリミジン誘導体
WO2005111024A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
JP2007537230A (ja)	2004-05-14	2007-12-20	ファイザー・プロダクツ・インク	異常細胞増殖の処置用のピリミジン誘導体
US8258145B2 (en)	2005-01-03	2012-09-04	Myrexis, Inc.	Method of treating brain cancer
CA2592900A1 (en)	2005-01-03	2006-07-13	Myriad Genetics Inc.	Nitrogen containing bicyclic compounds and therapeutical use thereof
EP1868612A4 (en) *	2005-03-25	2010-03-24	Glaxo Group Ltd	NOVEL CONNECTIONS
UY29440A1 (es) *	2005-03-25	2006-10-02	Glaxo Group Ltd	Nuevos compuestos
CN101495475A (zh) *	2005-03-25	2009-07-29	葛兰素集团有限公司	制备吡啶并[2,3-d]嘧啶-7-酮和3,4-二氢嘧啶并[4,5-d]嘧啶-2(1H)-酮衍生物的方法
PE20061193A1 (es)	2005-03-25	2006-12-02	Glaxo Group Ltd	DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
PT1888548E (pt)	2005-05-26	2012-10-30	Neuron Systems Inc	Derivado de quinolina para o tratamento de doenças da retina
ATE475660T1 (de)	2005-12-21	2010-08-15	Abbott Lab	Antivirale verbindungen
US7910595B2 (en)	2005-12-21	2011-03-22	Abbott Laboratories	Anti-viral compounds
EP2345652A1 (en)	2005-12-21	2011-07-20	Abbott Laboratories	Antiviral compounds
CN101384592A (zh) *	2005-12-21	2009-03-11	艾博特公司	抗病毒化合物
WO2007081517A2 (en)	2005-12-21	2007-07-19	Abbott Laboratories	Anti-viral compounds
EP2094276A4 (en)	2006-12-20	2011-01-05	Abbott Lab	ANTIVIRAL COMPOUNDS
SG172060A1 (en)	2008-12-09	2011-07-28	Gilead Sciences Inc	Modulators of toll-like receptors
US8551996B2 (en) *	2009-02-20	2013-10-08	Emory University	Compounds, compositions, methods of synthesis, and methods of treatment
AU2010292102B2 (en)	2009-09-14	2015-04-09	Gilead Sciences, Inc.	Modulators of Toll-like receptors
CA2782015C (en)	2009-12-11	2020-08-25	Neuron Systems, Inc.	Topical ophthalmic compositions and methods for the treatment of macular degeneration
US8754114B2 (en)	2010-12-22	2014-06-17	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
CN107652289B (zh)	2012-06-13	2020-07-21	因塞特控股公司	作为fgfr抑制剂的取代的三环化合物
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
CA3195807A1 (en)	2013-01-23	2014-07-31	Aldeyra Therapeutics, Inc.	Toxic aldehyde related diseases and treatment
KR102269032B1 (ko)	2013-04-19	2021-06-24	인사이트 홀딩스 코포레이션	Fgfr 저해제로서 이환식 헤테로사이클
US10882868B2 (en)	2014-05-15	2021-01-05	Hoffmann-La Roche Inc.	Compounds for treating spinal muscular atrophy
EA035068B1 (ru) *	2014-05-15	2020-04-23	Ф. Хоффманн-Ля Рош Аг	Соединения для лечения спинальной мышечной атрофии
CN113577081A (zh)	2014-07-11	2021-11-02	吉利德科学公司	用于治疗hiv的toll样受体调节剂
ES2845205T3 (es)	2014-09-16	2021-07-26	Gilead Sciences Inc	Métodos para preparar moduladores de receptores tipo Toll
UY36298A (es)	2014-09-16	2016-04-29	Gilead Science Inc	Formas sólidas de un modulador del receptor tipo toll
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
PE20171514A1 (es)	2015-02-20	2017-10-20	Incyte Corp	Heterociclos biciclicos como inhibidores de fgfr
EP3317278B1 (en)	2015-07-01	2021-04-14	Crinetics Pharmaceuticals, Inc.	Somatostatin modulators and uses thereof
MX2018002155A (es)	2015-08-21	2018-06-08	Aldeyra Therapeutics Inc	Compuestos deuterados y usos de los mismos.
MX379159B (es)	2016-02-12	2025-03-10	Astellas Pharma Inc	Derivados de tetrahidroisoquinolina.
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
EP3658560A4 (en)	2017-07-25	2021-01-06	Crinetics Pharmaceuticals, Inc.	SOMATOSTAT IN MODULATORS AND USES THEREOF
JP7311162B2 (ja) *	2017-10-10	2023-07-19	アルデイラセラピューティクス，インコーポレイテッド	炎症性障害の処置
SG11202010636VA (en)	2018-05-04	2020-11-27	Incyte Corp	Solid forms of an fgfr inhibitor and processes for preparing the same
BR112020022373A2 (pt)	2018-05-04	2021-02-02	Incyte Corporation	sais de um inibidor de fgfr
US12006298B2 (en)	2018-08-06	2024-06-11	Aldeyra Therapeutics, Inc.	Polymorphic compounds and uses thereof
CN113056353B (zh)	2018-09-25	2022-11-01	奥尔德拉医疗公司	用于治疗干眼病的调配物
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
US11786518B2 (en)	2019-03-26	2023-10-17	Aldeyra Therapeutics, Inc.	Ophthalmic formulations and uses thereof
CN113784954A (zh)	2019-05-02	2021-12-10	奥尔德拉医疗公司	多晶型化合物和其用途
WO2020223717A1 (en)	2019-05-02	2020-11-05	Aldeyra Therapeutics, Inc.	Process for preparation of aldehyde scavenger and intermediates
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021076602A1 (en)	2019-10-14	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CN115151539A (zh)	2019-12-04	2022-10-04	因赛特公司	Fgfr抑制剂的衍生物
JP7720840B2 (ja)	2019-12-04	2025-08-08	インサイト・コーポレイション	Ｆｇｆｒ阻害剤としての三環式複素環
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP2023526016A (ja)	2020-05-13	2023-06-20	アルデイラセラピューティクス，インコーポレイテッド	医薬製剤およびその使用
US12065494B2 (en)	2021-04-12	2024-08-20	Incyte Corporation	Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
AR126102A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr
CA3220155A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4605642A (en)	1984-02-23	1986-08-12	The Salk Institute For Biological Studies	CRF antagonists
US5063245A (en)	1990-03-28	1991-11-05	Nova Pharmaceutical Corporation	Corticotropin-releasing factor antagonism compounds
AU661533B2 (en) *	1992-01-20	1995-07-27	Astrazeneca Ab	Quinazoline derivatives
PL176526B1 (pl) *	1992-12-17	1999-06-30	Pfizer	Pirolopirymidyny jako związki o działaniu antagonistów czynnika uwalniającego kortykotropinę
TW444018B (en) *	1992-12-17	2001-07-01	Pfizer	Pyrazolopyrimidines
IL112249A (en)	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
TW574214B (en) *	1994-06-08	2004-02-01	Pfizer	Corticotropin releasing factor antagonists
JP2891544B2 (ja) *	1994-06-16	1999-05-17	ファイザー・インコーポレーテッド	ピラゾロおよびピロロピリジン類
JP2898887B2 (ja) *	1994-08-31	1999-06-02	沖電気工業株式会社	Ｉｃカードの読み取り装置
EP0729758A3 (en) *	1995-03-02	1997-10-29	Pfizer	Pyrazolopyrimidines and pyrrolopyrimidines for the treatment of neuronal and other diseases
AU716993B2 (en) *	1995-05-12	2000-03-16	Neurogen Corporation	Novel deazapurine derivatives; a new class of CRF1 specific ligands
US6403599B1 (en) *	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
EP0778277B1 (en) *	1995-12-08	2003-06-25	Pfizer Inc.	Substituted heterocyclic derivatives as CRF antagonists
PT880523E (pt)	1996-02-07	2007-01-31	Neurocrine Biosciences Inc	Pirazolopirimidinas com antagonistas dos receptores de crf
TW477787B (en)	1996-08-27	2002-03-01	Pfizer	Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same

1997
- 1997-07-23 PL PL97331602A patent/PL331602A1/xx unknown
- 1997-07-23 CZ CZ1999411A patent/CZ292806B6/cs not_active IP Right Cessation
- 1997-07-23 YU YU5399A patent/YU5399A/sh unknown
- 1997-07-23 DK DK97929472T patent/DK0920429T3/da active
- 1997-07-23 DE DE69719193T patent/DE69719193T2/de not_active Expired - Fee Related
- 1997-07-23 CN CN97197079A patent/CN1093130C/zh not_active Expired - Fee Related
- 1997-07-23 US US09/242,076 patent/US6492520B1/en not_active Expired - Fee Related
- 1997-07-23 CA CA002262692A patent/CA2262692C/en not_active Expired - Fee Related
- 1997-07-23 NZ NZ333727A patent/NZ333727A/xx unknown
- 1997-07-23 JP JP50775498A patent/JP3345021B2/ja not_active Expired - Fee Related
- 1997-07-23 TR TR1999/00228T patent/TR199900228T2/xx unknown
- 1997-07-23 EP EP97929472A patent/EP0920429B1/en not_active Expired - Lifetime
- 1997-07-23 IL IL12818897A patent/IL128188A0/xx unknown
- 1997-07-23 BR BR9710808A patent/BR9710808A/pt not_active Application Discontinuation
- 1997-07-23 AU AU33563/97A patent/AU709203B2/en not_active Ceased
- 1997-07-23 KR KR1019997001005A patent/KR20000029843A/ko not_active Abandoned
- 1997-07-23 WO PCT/IB1997/000918 patent/WO1998005661A1/en not_active Ceased
- 1997-07-23 ES ES97929472T patent/ES2191183T3/es not_active Expired - Lifetime
- 1997-07-23 EA EA199900083A patent/EA003188B1/ru not_active IP Right Cessation
- 1997-07-23 AT AT97929472T patent/ATE232863T1/de not_active IP Right Cessation
- 1997-07-23 SK SK140-99A patent/SK14099A3/sk unknown
- 1997-07-31 AP APAP/P/1997/001052A patent/AP1096A/en active
- 1997-08-04 GT GT199700089A patent/GT199700089A/es unknown
- 1997-08-04 TW TW086111115A patent/TW550265B/zh active
- 1997-08-05 CO CO97044966A patent/CO4900060A1/es unknown
- 1997-08-05 UY UY24655A patent/UY24655A1/es not_active IP Right Cessation
- 1997-08-05 PE PE1997000679A patent/PE97098A1/es not_active Application Discontinuation
- 1997-08-05 AR ARP970103560A patent/AR008829A1/es not_active Application Discontinuation
- 1997-08-05 ZA ZA976954A patent/ZA976954B/xx unknown
- 1997-08-05 PA PA19978435201A patent/PA8435201A1/es unknown
- 1997-08-05 ID IDP972708A patent/ID17980A/id unknown
- 1997-08-06 MA MA24755A patent/MA24296A1/fr unknown
- 1997-08-06 DZ DZ970139A patent/DZ2289A1/fr active
- 1997-08-06 TN TNTNSN97135A patent/TNSN97135A1/fr unknown
- 1997-08-06 HR HR970432A patent/HRP970432B1/xx not_active IP Right Cessation
- 1997-08-25 SA SA97180334A patent/SA97180334A/ar unknown
1999
- 1999-01-19 IS IS4948A patent/IS4948A/is unknown
- 1999-02-03 OA OA9900024A patent/OA10970A/en unknown
- 1999-02-03 BG BG103143A patent/BG103143A/xx unknown
- 1999-02-05 NO NO19990544A patent/NO313293B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PA8435201A1 (es)	1999-12-27
DK0920429T3 (da)	2003-05-12
DE69719193T2 (de)	2003-09-25
EA199900083A1 (ru)	1999-08-26
EP0920429B1 (en)	2003-02-19
AP1096A (en)	2002-08-26
CZ292806B6 (cs)	2003-12-17
SK14099A3 (en)	2000-05-16
CO4900060A1 (es)	2000-03-27
EA003188B1 (ru)	2003-02-27
NO313293B1 (no)	2002-09-09
UY24655A1 (es)	2000-09-29
WO1998005661A1 (en)	1998-02-12
KR20000029843A (ko)	2000-05-25
BG103143A (en)	1999-09-30
AU709203B2 (en)	1999-08-26
ID17980A (id)	1998-02-12
SA97180334A (ar)	2005-12-03
NO990544D0 (no)	1999-02-05
TW550265B (en)	2003-09-01
GT199700089A (es)	1999-01-26
JP2000501116A (ja)	2000-02-02
DZ2289A1 (fr)	2002-12-25
AP9701052A0 (en)	1997-10-31
EP0920429A1 (en)	1999-06-09
ES2191183T3 (es)	2003-09-01
HRP970432A2 (en)	1998-08-31
PL331602A1 (en)	1999-08-02
AR008829A1 (es)	2000-02-23
AU3356397A (en)	1998-02-25
ATE232863T1 (de)	2003-03-15
TNSN97135A1 (fr)	2005-03-15
CN1093130C (zh)	2002-10-23
PE97098A1 (es)	1999-01-12
ZA976954B (en)	1999-02-05
TR199900228T2 (xx)	1999-03-22
US6492520B1 (en)	2002-12-10
YU5399A (sh)	2002-03-18
MA24296A1 (fr)	1998-04-01
DE69719193D1 (de)	2003-03-27
CN1227552A (zh)	1999-09-01
CZ41199A3 (cs)	2000-01-12
NZ333727A (en)	2000-09-29
IS4948A (is)	1999-01-19
HRP970432B1 (en)	2002-10-31
JP3345021B2 (ja)	2002-11-18
BR9710808A (pt)	1999-08-17
HK1021734A1 (en)	2000-06-30
OA10970A (en)	2001-11-05
CA2262692A1 (en)	1998-02-12
NO990544L (no)	1999-03-31
CA2262692C (en)	2002-06-11

Publication	Publication Date	Title
HRP970432B1 (en)	2002-10-31	Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
HUP9903965A3 (en)	2002-02-28	Substituted 6,5-hetero-bicyclic derivatives
IL128049A0 (en)	1999-11-30	Substituted 6,6-hetero-bicyclic derivatives
GB2319250B (en)	1999-01-27	Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
IL141908A0 (en)	2002-03-10	1,4-benzodiazepine derivatives
IL145681A0 (en)	2002-06-30	Substituted 1,2,3,4-tetrahydronaphthalene derivatives
IL126624A0 (en)	1999-08-17	3-descladinose-2, 3-anhydroerythromycin derivatives
GB2311779B (en)	1999-07-14	2,3 benzodiazepine derivatives
ZA974953B (en)	1997-12-08	Substituted pyrazolylpyrazole derivatives.
PL330141A1 (en)	1999-04-26	Novel derivatives of 10,11-dihydro-10-oxo-5h-dibezyl(b,f)-azepin-5-carboxagmide
SG70589A1 (en)	2000-02-22	1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
IL126780A0 (en)	1999-08-17	Substituted 1,3-benzodioxoles
SI0920429T1 (en)	2003-06-30	Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
HUP9903001A3 (en)	2000-06-28	Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
IL132162A (en)	2000-08-13	2,3-epoxypropionamide derivatives
IL132162A0 (en)	2001-03-19	2, 3-Epoxypropionamide derivatives